Healthcare provider profile · identity verified

George P Koshy, MD

Family Practice · BRONX, NY · NPI 1689642639

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	751	87
Amlodipine Besylate	Amlodipine Besylate	557	56
Mirtazapine	Mirtazapine	395	40
Pantoprazole Sodium	Pantoprazole Sodium	296	46
Eliquis	Apixaban	287	38
Metoprolol Succinate	Metoprolol Succinate	287	33
Levothyroxine Sodium	Levothyroxine Sodium	276	32
Gabapentin	Gabapentin	264	35
Tamsulosin Hcl	Tamsulosin Hcl	232	36
Metformin Hcl	Metformin Hcl	229	25
Lisinopril	Lisinopril	226	26
Metoprolol Tartrate	Metoprolol Tartrate	187	26
Potassium Chloride	Potassium Chloride	182	34
Nifedipine Er	Nifedipine	181	24
Sertraline Hcl	Sertraline Hcl	176	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	155	19
Hydralazine Hcl	Hydralazine Hcl	153	16
Januvia	Sitagliptin Phosphate	141	19
Losartan Potassium	Losartan Potassium	135	17
Famotidine	Famotidine	134	17
Clopidogrel	Clopidogrel Bisulfate	124	16
Hydrochlorothiazide	Hydrochlorothiazide	112	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	111	11
Escitalopram Oxalate	Escitalopram Oxalate	107	11
Carvedilol	Carvedilol	99	22
Furosemide	Furosemide	98	16
Isosorbide Mononitrate Er	Isosorbide Mononitrate	96	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	91	11
Donepezil Hcl	Donepezil Hcl	90	suppressed
Midodrine Hcl	Midodrine Hcl	89	14
Rosuvastatin Calcium	Rosuvastatin Calcium	86	14
Simvastatin	Simvastatin	82	12
Latanoprost	Latanoprost	79	12
Levetiracetam	Levetiracetam	76	suppressed
Montelukast Sodium	Montelukast Sodium	73	suppressed
Risperidone	Risperidone	73	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	72	11
Finasteride	Finasteride	71	suppressed
Sodium Chloride	0.9 % Sodium Chloride	69	16
Brimonidine Tartrate	Brimonidine Tartrate	66	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	65	21
Benztropine Mesylate	Benztropine Mesylate	65	suppressed
Divalproex Sodium	Divalproex Sodium	65	suppressed
Haloperidol	Haloperidol	64	suppressed
Humalog Kwikpen U-100	Insulin Lispro	63	suppressed
Lactulose	Lactulose	63	20
Amiodarone Hcl	Amiodarone Hcl	62	suppressed
Entresto	Sacubitril/Valsartan	58	suppressed
Vancomycin Hcl	Vancomycin Hcl	51	13
Valsartan	Valsartan	48	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	47	47
Glipizide	Glipizide	46	suppressed
Tradjenta	Linagliptin	46	suppressed
Aripiprazole	Aripiprazole	45	suppressed
Ondansetron Hcl	Ondansetron Hcl	44	13
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	38	11
Carbidopa-Levodopa	Carbidopa/Levodopa	38	suppressed
Jardiance	Empagliflozin	38	suppressed
Timolol Maleate	Timolol Maleate	38	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	37	19
Omeprazole	Omeprazole	37	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	37	suppressed
Atenolol	Atenolol	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	36	suppressed
Pravastatin Sodium	Pravastatin Sodium	34	suppressed
Labetalol Hcl	Labetalol Hcl	33	suppressed
Ceftriaxone	Ceftriaxone Sodium	31	14
Enalapril Maleate	Enalapril Maleate	31	suppressed
Ezetimibe	Ezetimibe	31	suppressed
Lithium Carbonate	Lithium Carbonate	30	suppressed
Myrbetriq	Mirabegron	30	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	29	17
Torsemide	Torsemide	29	suppressed
Letrozole	Letrozole	28	suppressed
Albuterol Sulfate	Albuterol Sulfate	27	13
Citalopram Hbr	Citalopram Hydrobromide	27	suppressed
Trazodone Hcl	Trazodone Hcl	27	suppressed
Solifenacin Succinate	Solifenacin Succinate	26	suppressed
Santyl	Collagenase Clostridium Hist.	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	23	suppressed
Duloxetine Hcl	Duloxetine Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Ranolazine Er	Ranolazine	22	suppressed
Baclofen	Baclofen	21	suppressed
Caplyta	Lumateperone Tosylate	21	suppressed
Prednisone	Prednisone	21	suppressed
Teriflunomide	Teriflunomide	21	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	20	suppressed
Budesonide	Budesonide	20	suppressed
Calcium Acetate	Calcium Acetate	20	suppressed
Meloxicam	Meloxicam	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	19	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	19	13
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Pregabalin	Pregabalin	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Paroxetine Hcl	Paroxetine Hcl	17	suppressed
Dimethyl Fumarate	Dimethyl Fumarate	16	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	16	suppressed
Metformin Hcl Er	Metformin Hcl	16	suppressed
Zenpep	Lipase/Protease/Amylase	16	suppressed
Amantadine	Amantadine Hcl	15	suppressed
Meropenem	Meropenem	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	15	suppressed
Risperdal Consta	Risperidone Microspheres	15	suppressed
Arformoterol Tartrate	Arformoterol Tartrate	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Lidocaine Hcl	Lidocaine Hcl	14	suppressed
Oxacillin Sodium	Oxacillin Sodium	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Oxycodone Hcl	Oxycodone Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	12	suppressed
Ketoconazole	Ketoconazole	12	suppressed
Spironolactone	Spironolactone	12	suppressed
Allopurinol	Allopurinol	11	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	11	suppressed
Cyclosporine	Cyclosporine	11	suppressed
Insulin Aspart Flexpen	Insulin Aspart	11	suppressed
Nystop	Nystatin	11	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error